Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Oxford Immunotec Global PLC nets $68.8mm via IPO

Executive Summary

UK-based Oxford Immunotec Global PLC (develops diagnostics that measure effector T-cell response to certain antigens) netted $68.8mm in its initial public offering of 6.16mm ordinary shares (including the overallotment) at $12 on Nasdaq. The company originally thought it would sell the shares between $13 and $15.

Deal Industry
  • In Vitro Diagnostics
  • Laboratory Testing Services
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Cytology
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies